Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
© Lewis et al; licensee BioMed Central Ltd. 2004
Received: 07 March 2004
Accepted: 22 June 2004
Published: 22 June 2004
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|7 Mar 2004||Submitted||Original manuscript|
|16 Apr 2004||Reviewed||Reviewer Report - Marcus Quinkler|
|19 Apr 2004||Reviewed||Reviewer Report - Michael Fay|
|30 Apr 2004||Author responded||Author comments - John Wiebe|
|Resubmission - Version 2|
|30 Apr 2004||Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|10 Jun 2004||Reviewed||Reviewer Report - Marcus Quinkler|
|21 Jun 2004||Author responded||Author comments - John Wiebe|
|Resubmission - Version 4|
|21 Jun 2004||Submitted||Manuscript version 4|
|22 Jun 2004||Editorially accepted|
|22 Jun 2004||Article published||10.1186/1471-2407-4-27|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.